| Literature DB >> 18646609 |
Ikuo Shimizu1, Naoaki Ichikawa, Mihoko Yotsumoto, Masahiko Sumi, Mayumi Ueno, Hikaru Kobayashi.
Abstract
A 72-year-old male presented with oral bleeding resulting from acquired factor V (FV) inhibitor. We observed abnormalities in prothrombin time (PT) (8%) and activated partial thromboplastin time (APTT) (>200 seconds). FV activity was less than 3%, and a mixing test did not correlate with PT. FV inhibitor assay demonstrated 240 Bethesda units/ml. The patient also showed markedly decreased activity of Factors II (13%) and X (14%). Oral bleeding disappeared and coagulation abnormalities improved with prednisolone therapy. High titer FV inhibitor might affect coagulation assays even in a patient with normal factor activity.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18646609
Source DB: PubMed Journal: Rinsho Ketsueki ISSN: 0485-1439